Clear Need for Sensitive Diagnostic Markers for Pancreatic Cancer Surveillance
The diagnostic yield of pancreatic ductal adenocarcinoma was substantial in high-risk mutation carrier but non-existent in mutation-negative proven familial pancreatic cancer kindreds.
“Nevertheless, timely identification of resectable lesions proved challenging despite the concurrent use of two imaging modalities, with [endoscopic ultrasonography (EUS)] outperforming [MRI/cholangiopancreatography (MRI/MRCP)].” Read more . . .